Urinary neopterin excretion in patients with uterine sarcomas
暂无分享,去创建一个
E. Werner | D. Fuchs | G. Reibnegger | A. Hausen | H. Wachter | L. Fuith | H. Hetzel
[1] P. Comella,et al. Prognostic relevance of urinary neopterin in non‐Hodgkin's lymphomas , 1989, Cancer.
[2] W. Mann,et al. Use of serum CA‐125 in monitoring patients with uterine sarcoma: A preliminary report , 1988, Cancer.
[3] H. Kawasaki,et al. Prognostic significance of urinary neopterin levels in patients with hepatocellular carcinoma. , 1988, The Tohoku journal of experimental medicine.
[4] A. Berchuck,et al. Treatment of Uterine Leiomyosarcoma , 1988, Obstetrics and gynecology.
[5] E. Werner,et al. Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. , 1988, Immunology today.
[6] E. Werner,et al. Clinical significance of neopterin for prognosis and follow-up in ovarian cancer. , 1987, Cancer research.
[7] H Wachter,et al. Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix. , 1986, Cancer research.
[8] G. Isshiki,et al. URINARY NEOPTERIN IN CHILDREN WITH MALIGNANT NEOPLASM , 1985 .
[9] V. Schneider,et al. Uterine sarcoma: analysis of prognostic variables in 71 cases. , 1985, American journal of obstetrics and gynecology.
[10] D. Fuchs,et al. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma , 1984, The Journal of experimental medicine.
[11] D. Fuchs,et al. Determination of neopterine in human urine by reversed-phase high-performance liquid chromatography. , 1982, Journal of chromatography.
[12] E. Werner,et al. Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. , 1989, Advances in clinical chemistry.
[13] C. Zaloudek,et al. Mesenchymal Tumors of the Uterus , 1987 .
[14] P. Ekman,et al. Serum levels of neopterin as related to the prognosis of human prostatic carcinoma. , 1986, European Urology.